AML in Remission
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients (NCT04216771) | Fujian Medical University | 2020-01-01 |
Track AML in Remission automatically
Every clearance here is in the API, with alerts when new ones post.